Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

Shareholders of Boots ’ parent company, Walgreens Boots Alliance (WBA), have approved the company’s previously-announced ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a leading global pharmacy-led health and wellbeing company, with a presence in over 11 countries including the United States, Europe, and Latin America.

Review the current Walgreens Boots Alliance Inc (WBA:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if WBA is the best investment for you.

For Walgreens Boots Alliance (NASDAQ:WBA), the shifting market has hit them hard as well. Now, it’s pulling back on plans to offer an initial public offering (IPO) ...

Walgreens Boots Alliance's net debt of 1.9 times EBITDA suggests graceful use of debt. And the fact that its trailing twelve months of EBIT was 7.5 times its interest expenses harmonizes with that ...

Shares of NASDAQ WBA opened at $11.26 on Tuesday. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $22.05. The business’s 50-day moving average price is $10.86 and its ...